Literature DB >> 26036231

In situ molecular elucidation of drug supersaturation achieved by nano-sizing and amorphization of poorly water-soluble drug.

Keisuke Ueda1, Kenjirou Higashi1, Keiji Yamamoto1, Kunikazu Moribe2.   

Abstract

Quantitative evaluation of drug supersaturation and nanoparticle formation was conducted using in situ evaluation techniques, including nuclear magnetic resonance (NMR) spectroscopy. We prepared a ternary complex of carbamazepine (CBZ) with hydroxypropyl methylcellulose (HPMC) and sodium dodecyl sulfate (SDS) to improve the drug concentration. Different preparation methods, including grinding and spray drying, were performed to prepare the ternary component products, ground mixture (GM) and spray-dried sample (SD), respectively. Although CBZ was completely amorphized in the ternary SD, CBZ was partially amorphized with the remaining CBZ crystals in the ternary GM. Aqueous dispersion of the ternary GM formed nanoparticles of around 150 nm, originating from the CBZ crystals in the ternary GM. In contrast, the ternary SD formed transparent solutions without a precipitate. The molecular-level evaluation using NMR measurements revealed that approximately half a dose of CBZ in the ternary GM dispersion was present as nanoparticles; however, CBZ in the ternary SD was completely dissolved in the aqueous solution. The characteristic difference between the solid states, followed by different preparation methods, induced different solution characteristics in the ternary GM and SD. The permeation study, using a dialysis membrane, showed that the CBZ concentration dissolved in the bulk water phase rapidly reduced in the ternary SD dispersion compared to the ternary GM dispersion; this demonstrated the advantage of ternary GM dispersion in the maintenance of CBZ supersaturation. Long-term maintenance of a supersaturated state of CBZ observed in the ternary GM dispersion rather than in the ternary SD dispersion was achieved by the inhibition of CBZ crystallization owing to the existence of CBZ nanoparticles in the ternary GM dispersion. Nanoparticle formation, combined with drug amorphization, could be a promising approach to improve drug concentrations. The detailed elucidation of solution characteristics using in situ evaluation techniques will lead to the formation of useful solid dispersion and nanoparticle formulations, resulting in improved drug absorption.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous drug; Crystallization inhibition; NMR measurement; Nanoparticles; Supersaturated solution

Mesh:

Substances:

Year:  2015        PMID: 26036231     DOI: 10.1016/j.ejps.2015.05.027

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  5 in total

Review 1.  Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.

Authors:  Zonghua Tian; Yaping Mai; Tingting Meng; Shijie Ma; Guojing Gou; Jianhong Yang
Journal:  AAPS PharmSciTech       Date:  2021-06-14       Impact factor: 3.246

Review 2.  Performance Parameters and Characterizations of Nanocrystals: A Brief Review.

Authors:  Manasi M Chogale; Vinod N Ghodake; Vandana B Patravale
Journal:  Pharmaceutics       Date:  2016-08-30       Impact factor: 6.321

3.  Hydroxypropyl-β-cyclodextrin Enhances Oral Absorption of Silymarin Nanoparticles Prepared Using PureNano™ Continuous Crystallizer.

Authors:  Risako Onodera; Tomohiro Hayashi; Keiichi Motoyama; Kohei Tahara; Hirofumi Takeuchi
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

4.  Preliminary study of nanonized lamotrigine containing products for nasal powder formulation.

Authors:  Péter Gieszinger; Ildikó Csóka; Edina Pallagi; Gábor Katona; Orsolya Jójárt-Laczkovich; Piroska Szabó-Révész; Rita Ambrus
Journal:  Drug Des Devel Ther       Date:  2017-08-23       Impact factor: 4.162

Review 5.  Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.

Authors:  Leena Peltonen; Clare Strachan
Journal:  Molecules       Date:  2015-12-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.